Published in Head Neck on August 01, 2009
Physiology and prospects of bimanual tracheoesophageal brass instrument play. Acta Otorhinolaryngol Ital (2015) 0.75
Reflux symptoms in professional opera choristers. Gastroenterology (2007) 2.03
Successful closure of a postsurgical benign esophagomediastinal fistula by temporary placement of a polyester, expandable stent: Case report and review. Gastrointest Endosc (2002) 1.47
Genetic and acquired prothrombotic risk factors and sudden hearing loss. Laryngoscope (2007) 1.22
Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome. Oral Oncol (2005) 1.03
Association between hypermethylated tumor and paired surgical margins in head and neck squamous cell carcinomas. Clin Cancer Res (2007) 1.02
Prognostic impact of HER-2/neu expression on squamous head and neck carcinomas. Head Neck (2007) 0.96
beta-carotene supplementation in patients radically treated for stage I-II head and neck cancer: results of a randomized trial. Oncol Rep (2003) 0.91
Reliability and validity of the Italian nose obstruction symptom evaluation (I-NOSE) scale. Eur Arch Otorhinolaryngol (2013) 0.89
Docetaxel and vinorelbine: an effective regimen in recurrent squamous cell esophageal carcinoma. Med Oncol (2003) 0.88
Extracorporeal lithotripsy for salivary calculi: a long-term clinical experience. Laryngoscope (2004) 0.88
Alzheimer's disease-associated disability: an ICF approach. Disabil Rehabil (2005) 0.88
Overexpression of p27BBP in head and neck carcinomas and their lymph node metastases. Head Neck (2004) 0.86
Improved survival with perilymphatic interleukin 2 in patients with resectable squamous cell carcinoma of the oral cavity and oropharynx. Cancer (2002) 0.85
Postoperative adjuvant chemoradiotherapy in older patients with head and neck cancer. Arch Otolaryngol Head Neck Surg (2004) 0.85
13-cis retinoic acid in head and neck cancer chemoprevention: results of a randomized trial from the Italian Head and Neck Chemoprevention Study Group. Oncol Rep (2004) 0.84
Rehabilitative management of oropharyngeal dysphagia in acute care settings: data from a large Italian teaching hospital. Dysphagia (2007) 0.84
New therapy for orolaryngeal manifestations of Crohn's disease. Ann Otol Rhinol Laryngol (2003) 0.83
Voice quality after carbon dioxide laser and conventional surgery for T1A glottic carcinoma. J Voice (2004) 0.81
Histamine inhalation challenge in recurrent uvula angioedema. J Allergy Clin Immunol (2003) 0.80
Constitutive expression of interleukin-18 in head and neck squamous carcinoma cells. Head Neck (2004) 0.79
Docetaxel, carboplatin and concomitant radiotherapy for unresectable squamous cell carcinoma of the head and neck: pharmacokinetic and clinical data of a phase I-II study. Am J Clin Oncol (2004) 0.79
Long-term voice and swallowing modifications after supracricoid laryngectomy: objective, subjective, and self-assessment data. Am J Otolaryngol (2006) 0.78
Gemcitabine and vinorelbine in recurrent head and neck cancer: pharmacokinetic and clinical results. Anticancer Res (2003) 0.76
Reliability and validity of an instrument to measure quality of life in the dysarthric speaker. Folia Phoniatr Logop (2011) 0.75
The importance of preoperative swallowing therapy in subtotal laryngectomies. Otolaryngol Head Neck Surg (2009) 0.75
Development and validation of the children's voice handicap index-10 (CVHI-10). J Voice (2012) 0.75
Surgery and topic cidofovir for nasal squamous papillomatosis in HIV+ patient. Eur Arch Otorhinolaryngol (2008) 0.75
Neuromuscular Electrical Stimulation for Treatment-Refractory Chronic Dysphagia in Tube-Fed Patients: A Prospective Case Series. Folia Phoniatr Logop (2016) 0.75
The Relationship between Socioeconomic Status and Narrative Abilities in a Group of Italian Normally Developing Children. Folia Phoniatr Logop (2016) 0.75
A surgical technique for macrostoma reduction after laryngectomy. Otolaryngol Head Neck Surg (2006) 0.75